Loading
Latest filing published 17 Mar 2026 for Neurogene Inc., €71k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Stuart Cobb discloses dealings in Neurogene Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 13 March 2024 to 13 March 2026.
The open-market record consists of 4 sales worth €215k, with no purchase. Other entries cover 3 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The newest entry dates from 17 March 2026: an open-market sale of €2,836, in Neurogene Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations